Global Point-of-care Testing (POCT) for Infectious Diseases Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Point-of-care Testing (POCT) for Infectious Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Point-of-care Testing (POCT) for Infectious Diseases players cover Roche, Abbott, Siemens Healthineers, Danaher, BD, Assure Tech, BioMerieux, Bio-Rad Laboratories and Wondfo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Infectious Diseases Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Infectious Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Infectious Diseases sales for 2023 through 2029. With Point-of-care Testing (POCT) for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Infectious Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Infectious Diseases market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Point-of-care Testing (POCT) for Infectious Diseases market?
What factors are driving Point-of-care Testing (POCT) for Infectious Diseases market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-care Testing (POCT) for Infectious Diseases market opportunities vary by end market size?
How does Point-of-care Testing (POCT) for Infectious Diseases break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Point-of-care Testing (POCT) for Infectious Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Point-of-care Testing (POCT) for Infectious Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Point-of-care Testing (POCT) for Infectious Diseases players cover Roche, Abbott, Siemens Healthineers, Danaher, BD, Assure Tech, BioMerieux, Bio-Rad Laboratories and Wondfo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Infectious Diseases Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Infectious Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Infectious Diseases sales for 2023 through 2029. With Point-of-care Testing (POCT) for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Infectious Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Infectious Diseases market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Based on Colloidal Gold
- Based on Chemiluminescence
- Based on Fluorescence Immunochromatography
- Other
- Hospital
- lndependent Testing Organization
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Abbott
- Siemens Healthineers
- Danaher
- BD
- Assure Tech
- BioMerieux
- Bio-Rad Laboratories
- Wondfo
- Wuhan Easy Diagnosis
- Getein Biotech
- Beijing Hotgen Biotech Co.,ltd.
- Beijing Wantai BioPharm
- Zhejiang Orient Gene Biotech Co.,Ltd.
- Sansure Biotech Inc.
What is the 10-year outlook for the global Point-of-care Testing (POCT) for Infectious Diseases market?
What factors are driving Point-of-care Testing (POCT) for Infectious Diseases market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-care Testing (POCT) for Infectious Diseases market opportunities vary by end market size?
How does Point-of-care Testing (POCT) for Infectious Diseases break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Infectious Diseases by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Infectious Diseases by Country/Region, 2018, 2022 & 2029
2.2 Point-of-care Testing (POCT) for Infectious Diseases Segment by Type
2.2.1 Based on Colloidal Gold
2.2.2 Based on Chemiluminescence
2.2.3 Based on Fluorescence Immunochromatography
2.2.4 Other
2.3 Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
2.3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Type (2018-2023)
2.4 Point-of-care Testing (POCT) for Infectious Diseases Segment by Application
2.4.1 Hospital
2.4.2 lndependent Testing Organization
2.5 Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
2.5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Application (2018-2023)
3 GLOBAL POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company (2018-2023)
3.2.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Infectious Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Infectious Diseases Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
5.1.2 Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
5.2 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
5.3 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018-2023)
6.1.2 APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2018-2023)
6.2 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
6.3 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Infectious Diseases by Country
7.1.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
7.1.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
7.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
7.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
8.3 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Infectious Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Infectious Diseases Distributors
11.3 Point-of-care Testing (POCT) for Infectious Diseases Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Region (2024-2029)
12.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Type
12.7 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.1.3 Roche Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.2.3 Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Danaher
13.4.1 Danaher Company Information
13.4.2 Danaher Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.4.3 Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Danaher Main Business Overview
13.4.5 Danaher Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.5.3 BD Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Assure Tech
13.6.1 Assure Tech Company Information
13.6.2 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.6.3 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Assure Tech Main Business Overview
13.6.5 Assure Tech Latest Developments
13.7 BioMerieux
13.7.1 BioMerieux Company Information
13.7.2 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.7.3 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BioMerieux Main Business Overview
13.7.5 BioMerieux Latest Developments
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Information
13.8.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Rad Laboratories Main Business Overview
13.8.5 Bio-Rad Laboratories Latest Developments
13.9 Wondfo
13.9.1 Wondfo Company Information
13.9.2 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.9.3 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Wondfo Main Business Overview
13.9.5 Wondfo Latest Developments
13.10 Wuhan Easy Diagnosis
13.10.1 Wuhan Easy Diagnosis Company Information
13.10.2 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.10.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Easy Diagnosis Main Business Overview
13.10.5 Wuhan Easy Diagnosis Latest Developments
13.11 Getein Biotech
13.11.1 Getein Biotech Company Information
13.11.2 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.11.3 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Getein Biotech Main Business Overview
13.11.5 Getein Biotech Latest Developments
13.12 Beijing Hotgen Biotech Co.,ltd.
13.12.1 Beijing Hotgen Biotech Co.,ltd. Company Information
13.12.2 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.12.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Hotgen Biotech Co.,ltd. Main Business Overview
13.12.5 Beijing Hotgen Biotech Co.,ltd. Latest Developments
13.13 Beijing Wantai BioPharm
13.13.1 Beijing Wantai BioPharm Company Information
13.13.2 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.13.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Beijing Wantai BioPharm Main Business Overview
13.13.5 Beijing Wantai BioPharm Latest Developments
13.14 Zhejiang Orient Gene Biotech Co.,Ltd.
13.14.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
13.14.2 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.14.3 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhejiang Orient Gene Biotech Co.,Ltd. Main Business Overview
13.14.5 Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
13.15 Sansure Biotech Inc.
13.15.1 Sansure Biotech Inc. Company Information
13.15.2 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.15.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sansure Biotech Inc. Main Business Overview
13.15.5 Sansure Biotech Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Infectious Diseases by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Infectious Diseases by Country/Region, 2018, 2022 & 2029
2.2 Point-of-care Testing (POCT) for Infectious Diseases Segment by Type
2.2.1 Based on Colloidal Gold
2.2.2 Based on Chemiluminescence
2.2.3 Based on Fluorescence Immunochromatography
2.2.4 Other
2.3 Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
2.3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Type (2018-2023)
2.4 Point-of-care Testing (POCT) for Infectious Diseases Segment by Application
2.4.1 Hospital
2.4.2 lndependent Testing Organization
2.5 Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
2.5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Application (2018-2023)
3 GLOBAL POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company (2018-2023)
3.2.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Infectious Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Infectious Diseases Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
5.1.2 Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
5.2 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
5.3 Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018-2023)
6.1.2 APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2018-2023)
6.2 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
6.3 APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Infectious Diseases by Country
7.1.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
7.1.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
7.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
7.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Type
8.3 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Infectious Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Infectious Diseases Distributors
11.3 Point-of-care Testing (POCT) for Infectious Diseases Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Region (2024-2029)
12.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Type
12.7 Global Point-of-care Testing (POCT) for Infectious Diseases Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.1.3 Roche Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.2.3 Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Danaher
13.4.1 Danaher Company Information
13.4.2 Danaher Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.4.3 Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Danaher Main Business Overview
13.4.5 Danaher Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.5.3 BD Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Assure Tech
13.6.1 Assure Tech Company Information
13.6.2 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.6.3 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Assure Tech Main Business Overview
13.6.5 Assure Tech Latest Developments
13.7 BioMerieux
13.7.1 BioMerieux Company Information
13.7.2 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.7.3 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BioMerieux Main Business Overview
13.7.5 BioMerieux Latest Developments
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Information
13.8.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Rad Laboratories Main Business Overview
13.8.5 Bio-Rad Laboratories Latest Developments
13.9 Wondfo
13.9.1 Wondfo Company Information
13.9.2 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.9.3 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Wondfo Main Business Overview
13.9.5 Wondfo Latest Developments
13.10 Wuhan Easy Diagnosis
13.10.1 Wuhan Easy Diagnosis Company Information
13.10.2 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.10.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Easy Diagnosis Main Business Overview
13.10.5 Wuhan Easy Diagnosis Latest Developments
13.11 Getein Biotech
13.11.1 Getein Biotech Company Information
13.11.2 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.11.3 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Getein Biotech Main Business Overview
13.11.5 Getein Biotech Latest Developments
13.12 Beijing Hotgen Biotech Co.,ltd.
13.12.1 Beijing Hotgen Biotech Co.,ltd. Company Information
13.12.2 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.12.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Hotgen Biotech Co.,ltd. Main Business Overview
13.12.5 Beijing Hotgen Biotech Co.,ltd. Latest Developments
13.13 Beijing Wantai BioPharm
13.13.1 Beijing Wantai BioPharm Company Information
13.13.2 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.13.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Beijing Wantai BioPharm Main Business Overview
13.13.5 Beijing Wantai BioPharm Latest Developments
13.14 Zhejiang Orient Gene Biotech Co.,Ltd.
13.14.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
13.14.2 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.14.3 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhejiang Orient Gene Biotech Co.,Ltd. Main Business Overview
13.14.5 Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
13.15 Sansure Biotech Inc.
13.15.1 Sansure Biotech Inc. Company Information
13.15.2 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
13.15.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sansure Biotech Inc. Main Business Overview
13.15.5 Sansure Biotech Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Point-of-care Testing (POCT) for Infectious Diseases Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Infectious Diseases Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Based on Colloidal Gold
Table 4. Major Players of Based on Chemiluminescence
Table 5. Major Players of Based on Fluorescence Immunochromatography
Table 6. Major Players of Other
Table 7. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 8. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Table 9. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Type (2018-2023) & ($ million)
Table 10. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2018-2023)
Table 11. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 13. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Table 14. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Application (2018-2023)
Table 15. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application (2018-2023)
Table 16. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Company (2018-2023) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company (2018-2023)
Table 19. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company (2018-2023)
Table 21. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Producing Area Distribution and Sales Area
Table 23. Players Point-of-care Testing (POCT) for Infectious Diseases Products Offered
Table 24. Point-of-care Testing (POCT) for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Geographic Region (2018-2023)
Table 29. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country/Region (2018-2023)
Table 33. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 36. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 37. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 39. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 40. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 41. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018-2023) & (K Units)
Table 42. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region (2018-2023)
Table 43. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Region (2018-2023)
Table 45. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 46. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 47. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 48. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 49. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 51. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 52. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Infectious Diseases
Table 60. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Infectious Diseases
Table 61. Key Industry Trends of Point-of-care Testing (POCT) for Infectious Diseases
Table 62. Point-of-care Testing (POCT) for Infectious Diseases Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Point-of-care Testing (POCT) for Infectious Diseases Distributors List
Table 65. Point-of-care Testing (POCT) for Infectious Diseases Customer List
Table 66. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Roche Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 82. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Abbott Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 87. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Main Business
Table 89. Abbott Latest Developments
Table 90. Siemens Healthineers Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 91. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 92. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Siemens Healthineers Main Business
Table 94. Siemens Healthineers Latest Developments
Table 95. Danaher Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 96. Danaher Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 97. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Danaher Main Business
Table 99. Danaher Latest Developments
Table 100. BD Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 101. BD Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 102. BD Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BD Main Business
Table 104. BD Latest Developments
Table 105. Assure Tech Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 106. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 107. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Assure Tech Main Business
Table 109. Assure Tech Latest Developments
Table 110. BioMerieux Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 111. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 112. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. BioMerieux Main Business
Table 114. BioMerieux Latest Developments
Table 115. Bio-Rad Laboratories Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 116. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 117. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bio-Rad Laboratories Main Business
Table 119. Bio-Rad Laboratories Latest Developments
Table 120. Wondfo Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 121. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 122. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Wondfo Main Business
Table 124. Wondfo Latest Developments
Table 125. Wuhan Easy Diagnosis Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 126. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 127. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wuhan Easy Diagnosis Main Business
Table 129. Wuhan Easy Diagnosis Latest Developments
Table 130. Getein Biotech Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 131. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 132. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Getein Biotech Main Business
Table 134. Getein Biotech Latest Developments
Table 135. Beijing Hotgen Biotech Co.,ltd. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 136. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 137. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Beijing Hotgen Biotech Co.,ltd. Main Business
Table 139. Beijing Hotgen Biotech Co.,ltd. Latest Developments
Table 140. Beijing Wantai BioPharm Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 141. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 142. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Beijing Wantai BioPharm Main Business
Table 144. Beijing Wantai BioPharm Latest Developments
Table 145. Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 146. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 147. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Zhejiang Orient Gene Biotech Co.,Ltd. Main Business
Table 149. Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
Table 150. Sansure Biotech Inc. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 151. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 152. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Sansure Biotech Inc. Main Business
Table 154. Sansure Biotech Inc. Latest Developments
Table 1. Point-of-care Testing (POCT) for Infectious Diseases Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Infectious Diseases Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Based on Colloidal Gold
Table 4. Major Players of Based on Chemiluminescence
Table 5. Major Players of Based on Fluorescence Immunochromatography
Table 6. Major Players of Other
Table 7. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 8. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Table 9. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Type (2018-2023) & ($ million)
Table 10. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2018-2023)
Table 11. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 13. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Table 14. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Application (2018-2023)
Table 15. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application (2018-2023)
Table 16. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Company (2018-2023) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company (2018-2023)
Table 19. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company (2018-2023)
Table 21. Global Point-of-care Testing (POCT) for Infectious Diseases Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Point-of-care Testing (POCT) for Infectious Diseases Producing Area Distribution and Sales Area
Table 23. Players Point-of-care Testing (POCT) for Infectious Diseases Products Offered
Table 24. Point-of-care Testing (POCT) for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Geographic Region (2018-2023)
Table 29. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Point-of-care Testing (POCT) for Infectious Diseases Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country/Region (2018-2023)
Table 33. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 36. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 37. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 39. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 40. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 41. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018-2023) & (K Units)
Table 42. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region (2018-2023)
Table 43. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Region (2018-2023)
Table 45. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 46. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 47. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 48. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 49. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 51. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 52. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Infectious Diseases
Table 60. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Infectious Diseases
Table 61. Key Industry Trends of Point-of-care Testing (POCT) for Infectious Diseases
Table 62. Point-of-care Testing (POCT) for Infectious Diseases Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Point-of-care Testing (POCT) for Infectious Diseases Distributors List
Table 65. Point-of-care Testing (POCT) for Infectious Diseases Customer List
Table 66. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Roche Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 82. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Abbott Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 87. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Main Business
Table 89. Abbott Latest Developments
Table 90. Siemens Healthineers Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 91. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 92. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Siemens Healthineers Main Business
Table 94. Siemens Healthineers Latest Developments
Table 95. Danaher Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 96. Danaher Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 97. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Danaher Main Business
Table 99. Danaher Latest Developments
Table 100. BD Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 101. BD Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 102. BD Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BD Main Business
Table 104. BD Latest Developments
Table 105. Assure Tech Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 106. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 107. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Assure Tech Main Business
Table 109. Assure Tech Latest Developments
Table 110. BioMerieux Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 111. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 112. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. BioMerieux Main Business
Table 114. BioMerieux Latest Developments
Table 115. Bio-Rad Laboratories Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 116. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 117. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bio-Rad Laboratories Main Business
Table 119. Bio-Rad Laboratories Latest Developments
Table 120. Wondfo Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 121. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 122. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Wondfo Main Business
Table 124. Wondfo Latest Developments
Table 125. Wuhan Easy Diagnosis Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 126. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 127. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wuhan Easy Diagnosis Main Business
Table 129. Wuhan Easy Diagnosis Latest Developments
Table 130. Getein Biotech Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 131. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 132. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Getein Biotech Main Business
Table 134. Getein Biotech Latest Developments
Table 135. Beijing Hotgen Biotech Co.,ltd. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 136. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 137. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Beijing Hotgen Biotech Co.,ltd. Main Business
Table 139. Beijing Hotgen Biotech Co.,ltd. Latest Developments
Table 140. Beijing Wantai BioPharm Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 141. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 142. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Beijing Wantai BioPharm Main Business
Table 144. Beijing Wantai BioPharm Latest Developments
Table 145. Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 146. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 147. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Zhejiang Orient Gene Biotech Co.,Ltd. Main Business
Table 149. Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
Table 150. Sansure Biotech Inc. Basic Information, Point-of-care Testing (POCT) for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 151. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product Portfolios and Specifications
Table 152. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Sansure Biotech Inc. Main Business
Table 154. Sansure Biotech Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Point-of-care Testing (POCT) for Infectious Diseases
Figure 2. Point-of-care Testing (POCT) for Infectious Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Based on Colloidal Gold
Figure 10. Product Picture of Based on Chemiluminescence
Figure 11. Product Picture of Based on Fluorescence Immunochromatography
Figure 12. Product Picture of Other
Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type in 2022
Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2018-2023)
Figure 15. Point-of-care Testing (POCT) for Infectious Diseases Consumed in Hospital
Figure 16. Global Point-of-care Testing (POCT) for Infectious Diseases Market: Hospital (2018-2023) & (K Units)
Figure 17. Point-of-care Testing (POCT) for Infectious Diseases Consumed in lndependent Testing Organization
Figure 18. Global Point-of-care Testing (POCT) for Infectious Diseases Market: lndependent Testing Organization (2018-2023) & (K Units)
Figure 19. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2022)
Figure 20. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application in 2022
Figure 21. Point-of-care Testing (POCT) for Infectious Diseases Sales Market by Company in 2022 (K Units)
Figure 22. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company in 2022
Figure 23. Point-of-care Testing (POCT) for Infectious Diseases Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company in 2022
Figure 25. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 28. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 29. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 30. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 31. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 32. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 35. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 36. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 37. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 38. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 39. United States Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region in 2022
Figure 44. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Regions in 2022
Figure 45. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 46. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 47. China Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 55. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 56. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 57. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 58. Germany Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 67. Egypt Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases in 2022
Figure 73. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
Figure 74. Industry Chain Structure of Point-of-care Testing (POCT) for Infectious Diseases
Figure 75. Channels of Distribution
Figure 76. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Forecast by Region (2024-2029)
Figure 77. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Point-of-care Testing (POCT) for Infectious Diseases
Figure 2. Point-of-care Testing (POCT) for Infectious Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Point-of-care Testing (POCT) for Infectious Diseases Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Based on Colloidal Gold
Figure 10. Product Picture of Based on Chemiluminescence
Figure 11. Product Picture of Based on Fluorescence Immunochromatography
Figure 12. Product Picture of Other
Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type in 2022
Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Type (2018-2023)
Figure 15. Point-of-care Testing (POCT) for Infectious Diseases Consumed in Hospital
Figure 16. Global Point-of-care Testing (POCT) for Infectious Diseases Market: Hospital (2018-2023) & (K Units)
Figure 17. Point-of-care Testing (POCT) for Infectious Diseases Consumed in lndependent Testing Organization
Figure 18. Global Point-of-care Testing (POCT) for Infectious Diseases Market: lndependent Testing Organization (2018-2023) & (K Units)
Figure 19. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2022)
Figure 20. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Application in 2022
Figure 21. Point-of-care Testing (POCT) for Infectious Diseases Sales Market by Company in 2022 (K Units)
Figure 22. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Company in 2022
Figure 23. Point-of-care Testing (POCT) for Infectious Diseases Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Company in 2022
Figure 25. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 28. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 29. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 30. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 31. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 32. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue 2018-2023 ($ Millions)
Figure 35. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 36. Americas Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 37. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 38. Americas Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 39. United States Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Region in 2022
Figure 44. APAC Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Regions in 2022
Figure 45. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 46. APAC Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 47. China Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 55. Europe Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 56. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 57. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 58. Germany Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share by Application (2018-2023)
Figure 67. Egypt Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Point-of-care Testing (POCT) for Infectious Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases in 2022
Figure 73. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
Figure 74. Industry Chain Structure of Point-of-care Testing (POCT) for Infectious Diseases
Figure 75. Channels of Distribution
Figure 76. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Forecast by Region (2024-2029)
Figure 77. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Market Share Forecast by Application (2024-2029)
